Showing results (251-260 of 270) with videos related to

Sort By:
Pageof 27
The New England Journal of Medicine|February 18, 2026
An Antibody-Oligonucleotide Conjugate for Myotonic Dystrophy Type 1Nicholas E Johnson, Li-Jung Tai, Johanna I Hamel, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2026
Tissue nanotransfection-mediated induction of neurogenic programs promotes myoprotective responses in denervated skeletal muscleAna I Salazar-Puerta, Sara Kheirkhah, Jordan T Moore, et al.
The Journal of Clinical Investigation|January 17, 2018
OATP1B2 deficiency protects against paclitaxel-induced neurotoxicityAlix F Leblanc, Jason A Sprowl, Paola Alberti, et al.
American Journal of Physical Medicine & Rehabilitation|April 14, 2021
Evidence-Based Medicine Training in United States-Based Physiatry Residency ProgramsThiru M Annaswamy, John-Ross Rizzo, Amy Schnappinger, et al.
Science Advances|April 8, 2026
Vasculogenic tissue nanotransfection accelerates functional recovery after peripheral nerve injuryAna I Salazar-Puerta, Sara Kheirkhah, Jonathan P Stranan, et al.
Elife|December 17, 2020
Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumoniaMichaela Gregorova, Daniel Morse, Tarcisio Brignoli, et al.
The Lancet. Neurology|February 21, 2023
Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trialCharles A Thornton, Richard Thomas Moxley, Katy Eichinger, et al.
Cancers|February 24, 2024
Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) Samples from Advanced Non-Small Cell Lung Cancer for Whole Genome, Whole Exome and Comprehensive Panel SequencingDavid Fielding, Vanessa Lakis, Andrew J Dalley, et al.
The Journal of Clinical Investigation|July 9, 2026
Neuromuscular junction failure in sarcopenia is linked to NaV1.4 loss and reversed by ClC-1 inhibitionW David Arnold, Jeanette Jeppesen Morgen, Pernille Bogetofte Thomasen, et al.
Contemporary Clinical Trials Communications|August 11, 2018
Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA!Amy Bartlett, Stephen J Kolb, Allison Kingsley, et al.
Pageof 27